Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Medicenna Therapeutics Inc.
DescriptionHuman pro-apoptotic Type 2 IL-4 fusion
Molecular Target Interleukin-4 (IL-4) receptor (CD124) (IL-4RA)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationSolid tumors
Indication DetailsTreat non-CNS solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today